Dr. Martens plc (LON:DOCS)
London
· Delayed Price · Currency is GBP · Price in GBX | Market Cap | 634.55M |
| Revenue (ttm) | 805.90M |
| Net Income (ttm) | 29.40M |
| Shares Out | 964.36M |
| EPS (ttm) | 0.03 |
| PE Ratio | 21.60 |
| Forward PE | 16.79 |
| Dividend | 0.03 (3.88%) |
| Ex-Dividend Date | Mar 6, 2025 |
| Volume | 434,225 |
| Average Volume | 1,168,318 |
| Open | 65.70 |
| Previous Close | 66.25 |
| Day's Range | 65.40 - 69.00 |
| 52-Week Range | 49.32 - 100.00 |
| Beta | 0.05 |
| RSI | 34.68 |
| Earnings Date | Jun 5, 2025 |
About Dr. Martens
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company was founded in 1945 and is based in London, the United Kingdom. [Read more]
Financial Performance
In 2023, Dr. Martens's revenue was 877.10 million, a decrease of -12.32% compared to the previous year's 1.00 billion. Earnings were 69.20 million, a decrease of -46.31%.
Financial StatementsNews
Dr. Martens plc (DOCMF) Q3 2025 Sales/ Trading Statement Call Transcript
UK Stock Market News: Johnson Matthey, Dr Martens, Ryanair
Can Johnson Matthey placate activist investors? Q3 numbers show Dr Martens remains big in Japan, Ryanair update shows strong Christmas
FTSE 100 Live 27 January: Ryanair and Dr Martens post updates, index seen lower
'Welsh, fat and working-class is my superpower'
Over the past few years Megan Winstone has taken photographs for Vogue, Kerrang! and Dr. Martens.
Half Year 2025 Dr Martens PLC Earnings Call Transcript
Half Year 2025 Dr Martens PLC Earnings Call Transcript
Dr Martens boosted by good start to Christmas trading
Departing chief says bootmaker has started to stabilise after several profit warnings and poor performance in the US
Dr Martens’ shares jump 15% on new CEO’s start date despite drop in first half sales
Dr Martens said its new CEO Ije Nwokorie will take over from incumbent Kenny Wilson on Jan. 6 2025, in a shakeup investors hope could boost the struggling boot maker
Dr Martens Surges as Sales Rise and US Shows Signs of Recovery
Dr Martens Plc shares soared after the footwear company reported a better-than-expected interim performance and said it’s on track to meet targets unveiled earlier this year.
Dr Martens swings to loss and braces for currency hit
The bootmaker reported pre-tax losses of £28.7 million for the six months to September 29 against profits of £25.8 million the previous year.
Three Quick Facts: Direct Line, Loungers, Dr Martens
Aviva’s approach for Direct Line confirmed – and rejected, Loungers set to fold to private equity bid, headwinds persist at Dr Martens
Dr Martens sees strong US holiday sales, cuts inventory and debt
Dr Martens said on Thursday that the autumn-winter festive season had got off to an encouraging start and investors welcomed a reduction in net debt as the bootmaker tries to turn its performance arou...
FTSE 100 Live 28 November: Dr Martens posts results, Aviva and Direct Line shares in focus
Stock Picks From Seeking Alpha's October 2024 New Analysts
In October, 42 new analysts joined Seeking Alpha, sharing diverse investment ideas and strategies, from biotech to real estate. Highlighted strong buy recommendations include MicroStrategy, CorMedix, ...
Dr. Martens: Struggling To See The Downside At This Valuation
Dr Martens shares slump: should you give it the boot?
Over the past three years, Dr Martens has fallen out of fashion. Are the shares worth a look?
Dr. Martens shares plunge to record lows on discount bulk sale via Goldman Sachs
Dr. Martens' investors sold 70 million shares in the bootmaker at a price of 57.85 pence per share, in what marks a 10% discount on its closing share price on Thursday
Dr. Martens plc. (DOCMF) H2 2024 Earnings Call Transcript
Dr. Martens plc. (OTCPK:DOCMF) H2 2024 Earnings Conference Call May 30, 2024 4:30 AM ET Corporate Participants Kenneth Wilson - Chief Executive Officer Giles Wilson - Chief Financial Officer Conferenc...
Dr Martens will cut up to £25m in costs to counter weak US sales
British footwear brand does not rule out job losses, while profits fall by 43% to £97m
Dr. Martens Stock Plummets on Downbeat US Outlook
U.K.-listed Dr. Martens PLC issued a downbeat outlook for its U.S. sales on Tuesday, noting that it expects wholesale revenue in the country to be down by double digits for its fiscal 2025 year, and s...
Dr. Martens' profit warning highlights U.S. consumer-confidence challenge
Dr. Martens' profit warning sent shares of the iconic shoe brand tumbling Tuesday and spotlighted consumer-spending challenges on both sides of the Atlantic.
Dr. Martens Shares Tumble as Bootmaker Warns of Tough Year
Dr. Martens shares plummeted after the iconic British footwear and clothing brand said Chief Executive Officer Kenny Wilson plans to step down and warned of a challenging year ahead.
Dr. Martens shares lose a third of their value on U.S. warning
Shares of iconic shoe brand Dr. Martens fell as much as 32% on Tuesday with the company's U.S. business going so badly it needs to extend paying for additional storage space as it announced its chief ...
Dr. Martens shares plunge 30% to all-time low, trading briefly halted on weak outlook
Shares of Dr. Martens plunged to a record low in early deals after the shoemaker flagged a challenging 2025 outlook.
Bootmaker Dr Martens names new CEO, flags tough year on weak demand
British bootmaker Dr Martens named its chief brand officer Ije Nwokorie as its next CEO on Tuesday, saying Kenny Wilson had decided this year would be his final year as top boss.
Exclusive: Marathon Partners pushes Dr. Martens for strategic review, possible sale
Investment firm Marathon Partners Equity Management wants British boot maker Dr. Martens to hire bankers and begin an immediate strategic review that could lead to a sale of the company, according to ...